Development of a unique Bismuth (Bi-213) automated generator for use in cancer therapy.

被引：0
|
作者：
Bray, LA [1 ]
Tingey, JM [1 ]
DesChane, JR [1 ]
Egorov, OB [1 ]
机构：
[1] Pacific NW Natl Lab, Richland, WA USA
来源：
ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY | 1998年 / 216卷
关键词：
D O I：
暂无
中图分类号：
O6 [化学];
学科分类号：
0703 ;
摘要：
049-IEC
引用
收藏
页码：U927 / U927
页数：1
相关论文
共 50 条
  • [41] Development of functionally differentiating anti-CD73 antibodies for cancer therapy.
    Zhang, Zhenqing
    Jia, Yunli
    Miao, Xiaoniu
    Huang, Weifeng
    Wang, Chao
    Yuan, Zhijun
    Jiang, Wenchao
    Li, Zhiyuan
    Chen, Liandi
    Tsun, Andy
    CANCER RESEARCH, 2022, 82 (12)
  • [42] Search for biomarkers of stage II/III gastric cancer and development of individualized therapy.
    Oshima, Takashi
    Sakamoto, Naoya
    Yoshikawa, Takaki
    Rino, Yasushi
    Kunisaki, Chikara
    Yasui, Wataru
    Imada, Toshio
    Masuda, Munetaka
    JOURNAL OF CLINICAL ONCOLOGY, 2013, 31 (15)
  • [43] Pharmacokinetics and toxicity of 213Bi-labeled PAI2 in preclinical targeted alpha therapy for cancer
    Song, Emma Y.
    Rizvi, Syed M. Abbas
    Qu, Chang F.
    Raja, Chand
    Brechbiel, Martin W.
    Morgenstern, Alfred
    Apostolidis, Christos
    Allen, Barry J.
    CANCER BIOLOGY & THERAPY, 2007, 6 (06) : 898 - 904
  • [44] Preclinical safety studies of 213Bi labelled PAI2 for targeted alpha therapy of cancer
    Song, EY
    Qu, CF
    Rizvi, S
    Raja, C
    Morgenstern, A
    Apostolidis, C
    Allen, BJ
    ANNALS OF ONCOLOGY, 2006, 17 : 47 - 47
  • [45] Breakthrough of 225Ac and its radionuclide daughters from an 225Ac/213Bi generator:: development of new methods, quantitative characterization, and implications for clinical use
    Ma, DH
    McDevitt, MR
    Finn, RD
    Scheinberg, DA
    APPLIED RADIATION AND ISOTOPES, 2001, 55 (05) : 667 - 678
  • [46] Development of knowledge-based therapy for cancer: Identification of unique targets
    Rao, SGA
    NATIONAL MEDICAL JOURNAL OF INDIA, 1998, 11 (06): : 301 - 302
  • [47] Editorial: Kidney cancer - A unique opportunity for the development of disease specific therapy
    Linehan, WM
    JOURNAL OF UROLOGY, 2002, 168 (06): : 2411 - 2412
  • [48] Use of colorectal cancer subtypes identified through iterative clustering to predict response to therapy.
    Schlicker, Andreas
    Beran, Garry
    Chresta, Christine M.
    McWalter, Gael
    Pritchard, Alison
    Weston, Susie
    Runswick, Sarah
    Davenport, Sara
    Heathcote, Kerry
    Castro, Denis Alferez
    Orphanides, George
    French, Tim
    Wessels, Lodewyk F. A.
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (04)
  • [49] Development of chimeric forms of IFN-alpha for "on demand" in vivo cancer gene therapy.
    Fletcher, Jonathan S.
    Wu, Jianqiang
    Jessen, Walter J.
    Pundavela, Jay
    Dombi, Eva
    Kim, Mi-Ok
    Rizvi, Tilat A.
    Chetal, Kashish
    Salomonis, Nathan
    Ratner, Nancy
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (04) : 97 - 98
  • [50] Development of Hyaluronic acid-targeted Stigmasterol-Transferrin Nanoparticles for Cancer Therapy.
    Torres, Z.
    Delgado, Y.
    Griebenow, K. H.
    MOLECULAR BIOLOGY OF THE CELL, 2016, 27
12345